Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000950170-25-040279
Filing Date
2025-03-17
Accepted
2025-03-17 16:15:36
Documents
126
Period of Report
2024-12-31

Document Format Files

Seq Description Document Type Size
1 10-K gyre-20241231.htm   iXBRL 10-K 5482454
2 EX-4.1 gyre-ex4_1.htm EX-4.1 44000
3 EX-19.1 gyre-ex19_1.htm EX-19.1 119075
4 EX-21.1 gyre-ex21_1.htm EX-21.1 10280
5 EX-23.1 gyre-ex23_1.htm EX-23.1 4574
6 EX-31.1 gyre-ex31_1.htm EX-31.1 17579
7 EX-31.2 gyre-ex31_2.htm EX-31.2 17186
8 EX-32.1 gyre-ex32_1.htm EX-32.1 9009
9 EX-32.2 gyre-ex32_2.htm EX-32.2 8803
10 GRAPHIC img99844967_0.jpg GRAPHIC 266543
11 GRAPHIC img99844967_1.jpg GRAPHIC 219251
12 GRAPHIC img99844967_2.jpg GRAPHIC 155614
13 GRAPHIC img99844967_3.jpg GRAPHIC 70706
14 GRAPHIC img99844967_4.jpg GRAPHIC 111490
15 GRAPHIC img99844967_5.jpg GRAPHIC 269300
16 GRAPHIC img99844967_6.jpg GRAPHIC 2315
  Complete submission text file 0000950170-25-040279.txt   23690009

Data Files

Seq Description Document Type Size
17 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT gyre-20241231.xsd EX-101.SCH 2476192
129 EXTRACTED XBRL INSTANCE DOCUMENT gyre-20241231_htm.xml XML 4145150
Mailing Address 12770 HIGH BLUFF DRIVE, SUITE 150 SAN DIEGO CA 92130
Business Address 12770 HIGH BLUFF DRIVE, SUITE 150 SAN DIEGO CA 92130 (619) 949-3681
GYRE THERAPEUTICS, INC. (Filer) CIK: 0001124105 (see all company filings)

EIN.: 562020050 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-51173 | Film No.: 25744620
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)